Nicotine partially protects against paraquat‐induced nigrostriatal damage in mice; link to α6β2* nAChRs

Neuronal nicotinic receptors: from structure to pathology

Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970 · see citing works

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat

McCormack, A. L., Thiruchelvam, M. J., Manning-Bog, A., Thiffault, C., Langston, J. W., Cory‐Slechta, D. A., & Monte, D. A. D. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838 · see citing works

Genetics of Parkinson disease: paradigm shifts and future prospects

Farrer, M. J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1831 · Cited by 709 · see citing works

Nicotinic acetylcholine receptors and the regulation of neuronal signalling

Dajas‐Bailador, F., & Wonnacott, S. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.04.006 · Cited by 618 · see citing works

Environmental risk factors and Parkinson's disease

Liou, H., Tsai, M.-C., Chen, C., Jeng, J., Chang, Y. C., Chen, S. Y., & Chen, R.-T. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616 · see citing works

Subunit Composition of Functional Nicotinic Receptors in Dopaminergic Neurons Investigated with Knock-Out Mice

Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 505 · see citing works

Pesticides and Parkinson’s Disease—Is There a Link?

Brown, T., Rumsby, P., Capleton, A., Rushton, L., & Levy, L. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8095 · Cited by 446 · see citing works

Cholinergic interneuron characteristics and nicotinic properties in the striatum

Zhou, F., Wilson, C. J., & Dani, J. A. (2002) · Journal of Neurobiology · doi:10.1002/neu.10150 · Cited by 443 · see citing works

Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors

Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422 · see citing works

α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity

Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 412 · see citing works

Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum

Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407 · see citing works

Subunit Composition and Pharmacology of Two Classes of Striatal Presynaptic Nicotinic Acetylcholine Receptors Mediating Dopamine Release in Mice

Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works

The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 356 · see citing works

The role of glial cells in Parkinsonʼs disease

Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326 · see citing works

Smoking, nicotine and Parkinson's disease

Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 323 · see citing works

An inflammatory review of Parkinson's disease

Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309 · see citing works

α4β2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine

Moroni, M., Zwart, R., Sher, E., Cassels, B. K., & Bermúdez, I. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023044 · Cited by 286 · see citing works

Nicotine: from molecular mechanisms to behaviour

Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263 · see citing works

Regulation of Nicotinic Acetylcholine Receptor Numbers and Function by Chronic Nicotine Exposure

Gentry, C., & Lukas, R. (2002) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007023339184 · Cited by 232 · see citing works

Smoking and Parkinson’s disease

Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neurology · doi:10.1212/wnl.52.1.115 · Cited by 224 · see citing works

The β3 Nicotinic Receptor Subunit: A Component of α-Conotoxin MII-Binding Nicotinic Acetylcholine Receptors that Modulate Dopamine Release and Related Behaviors

Cui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11045.2003 · Cited by 213 · see citing works

Reactive Oxygen and Nitrogen Species: Weapons of Neuronal Destruction in Models of Parkinson's Disease

Przedborski, S., & Ischiropoulos, H. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.685 · Cited by 202 · see citing works

Smoking and Parkinson's disease: Systematic review of prospective studies

Allam, M. F., Campbell, M. J., Albert Hofman, D., del Castillo, A. S., & Navajas, R. F. (2004) · Movement Disorders · doi:10.1002/mds.20029 · Cited by 191 · see citing works

Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice

Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188 · see citing works

Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice

Sparks, J. A., & Pauly, J. R. (1999) · Psychopharmacology · doi:10.1007/s002130050818 · Cited by 188 · see citing works

The α7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca2+ dependent mechanism

Dajas‐Bailador, F., Lima, P. A., & Wonnacott, S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00127-1 · Cited by 182 · see citing works

The Role of Neuronal Nicotinic Acetylcholine Receptors in Acute and Chronic Neurodegeneration

O'Neill, M., Murray, T., Lakics, V., Visanji, N. P., & Duty, S. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339166 · Cited by 181 · see citing works

Central nicotinic receptors, neurotrophic factors and neuroprotection

Belluardo, N., Mudò, G., Blum, M., & Fuxé, K. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00197-2 · Cited by 176 · see citing works

<i>In vivo</i> nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice

Brunzell, D. H., Russell, D. S., & Picciotto, M. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01640.x · Cited by 176 · see citing works

[3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.

Perry, D. C., & Kellar, K. J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12091-0 · Cited by 163 · see citing works

125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain

Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26500-7 · Cited by 160 · see citing works

A Functional Role for Nicotine in Bcl2 Phosphorylation and Suppression of Apoptosis

Mai, H., May, W. S., Gao, F., Jin, Z., & Deng, X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209044200 · Cited by 158 · see citing works

125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.

Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · PubMed · Cited by 158 · see citing works

A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long‐term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?

Ossowska, K., Wardas, J., Śmiałowska, M., Kuter, K. Z., Lenda, T., Wierońska, J. M., Zieba, B. A., Nowak, P. G., Dąbrowska, J., Bortel, A. B., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04301.x · Cited by 145 · see citing works

Involvement of the α3 Subunit in Central Nicotinic Binding Populations

Whiteaker, P., Peterson, C. G., Xu, W., McIntosh, J. M., Paylor, R. E., Beaudet, A. L., Collins, A. C., & Marks, M. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02522.2002 · Cited by 145 · see citing works

Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates

Quik, M., Parameswaran, N., McCallum, S. E., Bordia, T., Bao, S., McCormack, A. L., Kim, A., Tyndale, R. F., Langston, J. W., & Monte, D. A. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04078.x · Cited by 137 · see citing works

Effects of (−)-nicotine and (−)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson’s disease

Soto‐Otero, R., Méndez‐Álvarez, E., Ameijeiras, Á. H., López-Real, A. M., & Labandeira-García, J. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01070-5 · Cited by 137 · see citing works

Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra11Published on the World Wide Web on 1 December 2000.

Costa, G., Abin-Carriquiry, J. A., & Dajas, F. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03087-0 · Cited by 134 · see citing works

Expression of Nigrostriatal α6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by β3 Subunit Gene Deletion

Gotti, C., Moretti, M., Clementi, F., Riganti, L., McIntosh, J. M., Collins, A. C., Marks, M. J., & Whiteaker, P. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011940 · Cited by 133 · see citing works

Analysis of 3-(4-Hydroxy, 2-Methoxybenzylidene)Anabaseine Selectivity and Activity at Human and Rat Alpha-7 Nicotinic Receptors

Meyer, E. M., Kuryatov, A., Gerzanich, V., Lindstrom, J. M., & Papke, R. L. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37881-4 · Cited by 131 · see citing works

Effects of l ‐dopa and other amino acids against paraquat‐induced nigrostriatal degeneration

McCormack, A. L., & Monte, D. A. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01621.x · Cited by 131 · see citing works

Nicotine Induces Multi-site Phosphorylation of Bad in Association with Suppression of Apoptosis

Jin, Z., Gao, F., Flagg, T. O., & Deng, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402566200 · Cited by 131 · see citing works

Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy

Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 127 · see citing works

Epidemiologic Approaches to the Study of Parkinsonʼs Disease Etiology

Checkoway, H., & Nelson, L. M. (1999) · Epidemiology · doi:10.1097/00001648-199905000-00023 · Cited by 122 · see citing works

Nicotine‐induced Protection Against Glutamate Cytotoxicity

Shimohama, S., AKAIKE, A., & Kimura, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34445.x · Cited by 118 · see citing works

Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin

Parain, K., Hapdey, C., Rousselet, E., Marchand, V., Dumery, B., & Hirsch, É. C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03195-0 · Cited by 114 · see citing works

Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection

Janson, A. M., Fuxé, K., Agnati, L. F., Kitayama, I. T., Härfstrand, A., Andersson, K., & Goldstein, M. (1988) · Brain Research · doi:10.1016/0006-8993(88)90092-3 · Cited by 114 · see citing works

Long-Term Nicotine Treatment Decreases Striatal α6* Nicotinic Acetylcholine Receptor Sites and Function in Mice

Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112 · see citing works

Characterization of Nicotinic Agonist-Induced [3H]Dopamine Release from Synaptosomes Prepared from Four Mouse Brain Regions

Grady, S. R., Murphy, K. L., Cao, J., Marks, M. J., McIntosh, J. M., & Collins, A. C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.651 · Cited by 110 · see citing works

Vulnerability of125I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey

Quik, M., Polonskaya, Y., Kulak, J. M., & McIntosh, J. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05494.2001 · Cited by 109 · see citing works

Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes

Hejmadi, M. V., Dajas‐Bailador, F., Barns, S. M., Jones, B. J., & Wonnacott, S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00244-6 · Cited by 104 · see citing works

Nicotine protects against arachidonic‐acid‐induced caspase activation, cytochrome c release and apoptosis of cultured spinal cord neurons

Garrido, R., Mattson, M. P., Hennig, B., & Toborek, M. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00135.x · Cited by 102 · see citing works

[125I]IPH, an Epibatidine Analog, Binds with High Affinity to Neuronal Nicotinic Cholinergic Receptors

Dávila‐García, M. I., Musachio, J. L., Perry, D. C., Xiao, Y., Horti, A. G., London, E. D., Dannals, R. F., & Kellar, K. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36785-0 · Cited by 90 · see citing works

Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons

Miñana, M., Montoliu, C., Llansola, M., Grisolı́a, S., & Felipo, V. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00074-4 · Cited by 90 · see citing works

Subunit Composition of Nicotinic Receptors in Monkey Striatum: Effect of Treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA

Quik, M., Vailati, S., Bordia, T., Kulak, J. M., Fan, H., McIntosh, J. M., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006015 · Cited by 86 · see citing works

Nicotine protects rat brain mitochondria against experimental injuries

Cormier, A., Morin, C., Zini, R., Tillement, J. P., & Lagrue, G. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00041-8 · Cited by 86 · see citing works

Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse

Janson, A. M., Fuxé, K., & Goldstein, M. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00184656 · Cited by 84 · see citing works

Differential Declines in Striatal Nicotinic Receptor Subtype Function after Nigrostriatal Damage in Mice

Quik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 83 · see citing works

Nicotine administration stimulates the in vivo N‐methyl‐ D ‐aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release

Fedele, E., Varnier, G., Ansaldo, M. A., & Raiteri, M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702130 · Cited by 79 · see citing works

Chronic Oral Nicotine Normalizes Dopaminergic Function and Synaptic Plasticity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Primates

Quik, M., Chen, L., Parameswaran, N., Xie, X., Langston, J. W., & McCallum, S. E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0215-06.2006 · Cited by 77 · see citing works

Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration

McCormack, A. L., Atienza, J. G., Langston, J. W., & Monte, D. A. D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.069 · Cited by 69 · see citing works

Investigating the Receptor-independent Neuroprotective Mechanisms of Nicotine in Mitochondria

Xie, Y., Bézard, E., & Zhao, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504664200 · Cited by 69 · see citing works

Stimulation of non-α7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture

Jeyarasasingam, G., Tompkins, L., & Quik, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00488-2 · Cited by 68 · see citing works

The subunit composition and pharmacology of α-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay

Salminen, O., Whiteaker, P., Grady, S. R., Collins, A. C., McIntosh, J. M., & Marks, M. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.011 · Cited by 63 · see citing works

Parkinson's disease risk factors: genetic, environmental, or both?

Allam, M. F., del Castillo, A. S., & Navajas, R. F. (2005) · Neurological Research · doi:10.1179/016164105x22057 · Cited by 58 · see citing works

Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke

Carr, L. A., & Rowell, P. P. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90019-n · Cited by 58 · see citing works

Loss of Nicotinic Receptors in Monkey Striatum after 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Treatment Is Due to a Decline in α-Conotoxin MII Sites

Kulak, J. M., McIntosh, J. M., & Quik, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.230 · Cited by 56 · see citing works

Decrease in α3*/α6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage

McCallum, S. E., Parameswaran, N., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012773 · Cited by 52 · see citing works

Chronic nicotine administration in the drinking water affects the striatal dopamine in mice

Pietilä, K., & Ahtee, L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00235-5 · Cited by 50 · see citing works

Nicotine Enhances 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Neurotoxicity

Behmand, R. A., & Harik, S. I. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09786.x · Cited by 50 · see citing works

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by β-naphthoflavone-pretreatment

Shahi, G. S., Das, N. P., & Moochhala, S. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90804-3 · Cited by 47 · see citing works

Chronic nicotine treatment attenuates α7 nicotinic receptor deficits following traumatic brain injury

Verbois, S. L. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00366-0 · Cited by 46 · see citing works

Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice

Parain, K., Marchand, V., Dumery, B., & Hirsch, É. C. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03198-x · Cited by 44 · see citing works

Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: A microdialysis study

Janson, A. M., Meana, J. J., Goiny, M., & Herrera‐Marschitz, M. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90515-u · Cited by 39 · see citing works

Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists.

Hadjiconstantinou, M., Hubble, J. P., Wemlinger, T. A., & Neff, N. H. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22396-5 · Cited by 37 · see citing works

Neurotoxin-based models of Parkinson's disease

Bové, J., & Perier, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.057 · Cited by 508 · see citing works

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum

Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · see citing works

Progress in Parkinson's disease—Where do we stand?

Toulouse, A., & Sullivan, A. M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.05.003 · Cited by 194 · see citing works

Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery

Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163 · see citing works

Nicotine and Parkinson's disease: implications for therapy

Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154 · see citing works

Multiple roles for nicotine in Parkinson's disease

Quik, M., Huang, L. Z., Parameswaran, N., Bordia, T., Campos, C., & Perez, X. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.003 · Cited by 134 · see citing works

Nicotine and inflammatory neurological disorders

Piao, W.-H., Campagnolo, D. I., Dayao, C. S., Lukas, R. J., Wu, J., & Shi, F. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.67 · Cited by 131 · see citing works

Nicotinic receptors as CNS targets for Parkinson's disease

Quik, M., Bordia, T., & O’Leary, K. T. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.015 · Cited by 116 · see citing works

Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone‐induced Parkinson's disease models

Takeuchi, H., Yanagida, T., Inden, M., Takata, K., Kitamura, Y., Yamakawa, K., Sawada, H., Izumi, Y., Yamamoto, N., Kihara, T., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21869 · Cited by 108 · see citing works

Advances made in removing paraquat herbicide by adsorption technology: A review

Franco, D. S. P., Georgin, J., Lima, E. C., & Silva, L. F. O. (2022) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2022.102988 · Cited by 95 · see citing works

Nicotine neuroprotection against nigrostriatal damage: importance of the animal model

Quik, M., O’Neill, M. J., & Perez, X. A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.03.001 · Cited by 93 · see citing works

Toxin-Induced and Genetic Animal Models of Parkinson's Disease

Hisahara, S., & Shimohama, S. (2010) · Parkinson s Disease · doi:10.4061/2011/951709 · Cited by 91 · see citing works

Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca 2+

Toulorge, D., Guerreiro, S., Hild, A., Maskos, U., Hirsch, É. C., & Michel, P. P. (2011) · The FASEB Journal · doi:10.1096/fj.11-182824 · Cited by 89 · see citing works

Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?

Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 86 · see citing works

Long-term nicotine treatment differentially regulates striatal α6α4β2* and α6(nonα4)β2* nAChR expression and function

Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048843 · Cited by 77 · see citing works

Mysterious α6-containing nAChRs: function, pharmacology, and pathophysiology

Yang, K., Jin, G.-Z., & Wu, J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.63 · Cited by 69 · see citing works

Cotinine selectively activates a subpopulation of α3/α6β2* nicotinic receptors in monkey striatum

O’Leary, K., Parameswaran, N., McIntosh, J. M., & Quik, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136838 · Cited by 45 · see citing works

Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance

Bencherif, M. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.37 · Cited by 44 · see citing works

Additive Protective Effects of Donepezil and Nicotine Against Salsolinol-Induced Cytotoxicity in SH-SY5Y Cells

Das, J. R., & Tizabi, Y. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9040-2 · Cited by 40 · see citing works

Preparation of methacrylic acid-modified rice husk improved by an experimental design and application for paraquat adsorption

Hsu, S., Chen, L., Lee, C., Pan, T.-C., You, B.-X., & Yan, Q.-F. (2009) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2009.06.144 · Cited by 37 · see citing works

Nicotine suppresses Parkinson’s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels

Carvajal-Oliveros, A., Domínguez-Baleón, C., Zárate, R. V., Campusano, J. M., Narváez‐Padilla, V., & Reynaud, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-88910-4 · Cited by 34 · see citing works

Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein

Subramaniam, S., Magen, I., Bove, N., Zhu, C., Lemesre, V., Dutta, G., Elias, C. J., Lester, H. A., & Chesselet, M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.018 · Cited by 33 · see citing works

Paraquat

Lock, E. A., & Wilks, M. F. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374367-1.00083-5 · Cited by 32 · see citing works

In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: Implications for Parkinson's Disease

Abin‐Carriquiry, J. A., Costa, G., Urbanavicius, J., Cassels, B. K., Rebolledo-Fuentes, M., Wonnacott, S., & Dajas, F. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.013 · Cited by 29 · see citing works

Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson’s Disease

Perez, X. A. (2015) · Neuropsychology Review · doi:10.1007/s11065-015-9303-z · Cited by 25 · see citing works

Primary hippocampal neuronal cell death induction after acute and repeated paraquat exposures mediated by AChE variants alteration and cholinergic and glutamatergic transmission disruption

del Pino, J., Moyano, P. M., Díaz, G. G., Anadón, M. J., Díaz, M. J. V., García, J. M., Lobo, M., Pelayo, A., Solà, E., & Frejo, M. T. (2017) · Toxicology · doi:10.1016/j.tox.2017.09.008 · Cited by 25 · see citing works

Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures

Sandström, J., Zoia, D., Althaus, J., Antinori, P., Mermoud, J., Pak, H. S., Scherl, A., & Monnet‐Tschudi, F. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.02.001 · Cited by 24 · see citing works

lynx1 Supports Neuronal Health in the Mouse Dorsal Striatum During Aging: an Ultrastructural Investigation

Kobayashi, A., Parker, R. L., Wright, A. P., Brahem, H., Ku, P., Oliver, K. M., Walz, A., Lester, H. A., & Miwa, J. M. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0352-1 · Cited by 22 · see citing works

Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.

Tizabi, Y., & Getachew, B. (2017) · PubMed · Cited by 19 · see citing works

Genetic basis of susceptibility to low‐dose paraquat and variation between the sexes in Drosophila melanogaster

Lovejoy, P. C., Foley, K. E., Conti, M. M., Meadows, S. M., Bishop, C., & Fiumera, A. C. (2021) · Molecular Ecology · doi:10.1111/mec.15878 · Cited by 18 · see citing works

Chronic Nicotine Treatment Increases nAChRs and Microglial Expression in Monkey Substantia Nigra After Nigrostriatal Damage

Quik, M., Campos, C., Parameswaran, N., Langston, J. W., McIntosh, J. M., & Yeluashvili, M. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9265-9 · Cited by 18 · see citing works

Primary hippocampal estrogenic dysfunction induces synaptic proteins alteration and neuronal cell death after single and repeated paraquat exposure

Moyano, P. M., Sanjuan, J., García, J. M., Anadón, M. J., Lobo, M., Pelayo, A., García, J., Frejo, M. T., & del Pino, J. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110961 · Cited by 16 · see citing works

Role of OCT3 and DRP1 in the Transport of Paraquat in Astrocytes: A Mouse Study

Han, S., Feng, Y., Guo, M. A., Hao, Y., Sun, J., Zhao, Y., Dong, Q., Zhao, Y., & Cui, M. (2022) · Environmental Health Perspectives · doi:10.1289/ehp9505 · Cited by 14 · see citing works

Neuroprotection in Parkinson's Disease: A Systematic Review of the Preclinical Data

Douna, H., Bavelaar, B. M., Pellikaan, H., Olivier, B., & Pieters, T. (2012) · The Open Pharmacology Journal · doi:10.2174/1874143601206010012 · Cited by 13 · see citing works

Paraquat Exposure Reduces Nicotinic Receptor-Evoked Dopamine Release in Monkey Striatum

O’Leary, K. T., Parameswaran, N., Johnston, L. C., McIntosh, J. M., Monte, D. A. D., & Quik, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141861 · Cited by 11 · see citing works

NOVEL AND EXTENSIVE ASPECTS OF PARAQUAT-INDUCED PULMONARY FIBROGENESIS: COMPARATIVE AND TIME-COURSE MICROARRAY ANALYSES IN FIBROGENIC AND NON-FIBROGENIC RATS

SATOMI, Y., 坂口, 和., Kasahara, Y., & Akahori, F. (2007) · The Journal of Toxicological Sciences · doi:10.2131/jts.32.529 · Cited by 11 · see citing works

Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits

Vieira‐Brock, P. L., McFadden, L. M., Nielsen, S. M., Ellis, J. D., Walters, E. T., Stout, K. A., McIntosh, J. M., Wilkins, D. G., Hanson, G. R., & Fleckenstein, A. E. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221945 · Cited by 10 · see citing works

Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors

Sandager‐Nielsen, K., Ahring, P. K., Klein, J. L., van Hout, M., Thaneshwaran, S., dos Santos, A. B., Jacobsen, T. A., Amrutkar, D. V., Peters, D., Jensen, A. A., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113786 · Cited by 8 · see citing works

Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors

van Hout, M., Klein, J. L., Ahring, P. K., Brown, D. T., Thaneshwaran, S., dos Santos, A. B., Jensen, A. A., Kohlmeier, K. A., Christophersen, P., & Dyhring, T. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113788 · Cited by 7 · see citing works

Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease

Kumari, N., Cooke, L., & Olsen, A. L. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251355112 · Cited by 6 · see citing works

Paraquat-induced Neurodegeneration: a Model of Parkinson's Disease Risk Factors

Monte, D. A. D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00015-4 · Cited by 4 · see citing works

Comparison Study of Paraquat Herbicide Adsorption by Xerogels: Application of Experimental Design

Shamsodin, M., Fazli, M., & Nasiri, M. (2018) · Environmental Progress & Sustainable Energy · doi:10.1002/ep.12947 · Cited by 4 · see citing works

In silico analysis of nicotine’s molecular targets in Parkinson’s disease

Nguyen, H. D. (2025) · Xenobiotica · doi:10.1080/00498254.2025.2519826 · Cited by 3 · see citing works

Cigarette Smoking and Neurological Disorders: From Exposure to Therapeutic Interventions

Khan, Y. H., Abid, A., Liaqat, A., Butt, M. H., Ahmad, A., Misbah, S., & Mallhi, T. H. (2021) · Emerging contaminants and associated treatment technologies · doi:10.1007/978-3-030-66376-6_6 · Cited by 3 · see citing works

Nicotine influences the motor performance of immature rats in two different sensorimotor tasks.

RILJAK, V., Maresova, D., Dohnalova, A., & Pokorny, J. (2011) · PubMed · Cited by 2 · see citing works

Adult-administered chronic nicotine remodels nigral dopaminergic and pedunculopontine cholinergic physiology

Chen, R. Y.-T., Hosseini, H., Hall, S., Zhang, S. Q., & Evans, R. C. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111219 · Cited by 1 · see citing works

Animal Models of Parkinson’s Disease Induced by Toxins and Genetic Manipulation

Hisahara, S., & Shimoham, S. (2012) · InTech eBooks · doi:10.5772/19860 · Cited by 1 · see citing works

A Role for Neuronal Nicotinic Acetylcholine Receptors in Dopamine-Mediated Behaviors and the Hypnotic Response to Anesthetics: A Dissertation

Soll, L. G. (2013) · eScholarship@UMassChan · doi:10.13028/m2ng64

Overview of Parkinson's Disease: Examing the role for the Gut-Brain-Gut axis and the use of Nutrients based on preclinical and clinical evidence

Koopman, H. J. M. (2013) · Utrecht University Repository (Utrecht University)

A Role for Nicotine in Neuroprotection Against Disorders Associated With Monoaminergic and Cognitive Dysfunction

de Lima Vieira Brock, P. (2019) · J. Willard Marriott Library · doi:10.26053/0j-t9x7-v964

Early Nicotine Exposure Is Protective in Familial and Idiopathic Models of Parkinson’s Disease

Buhlman, L. M., & Hu, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_11

Inhibition of Brain CYP2D Lowers Codeine-induced Analgesia in Rats

Zhou, K. (2012) · TSpace (University of Toronto)

Cellular, Behavioral, and Locomotor Effects of Oral Nicotine in Male Rats with Bilateral Lesions in the Ventrolateral Striatum Induced with 6-OHDA

Darol, E. S., Karson, A., Köktürk, S., & İşeri, P. (2023) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1162013

Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys

Huang, L. Z., Parameswaran, N., Bordia, T., McIntosh, J. M., & Quik, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06011.x · Cited by 94 · see citing works

Paraquat Exposure Reduces Nicotinic Receptor-Evoked Dopamine Release in Monkey Striatum

O’Leary, K. T., Parameswaran, N., Johnston, L. C., McIntosh, J. M., Monte, D. A. D., & Quik, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141861 · Cited by 11 · see citing works

Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice

Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188 · see citing works

Stimulation of non-α7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture

Jeyarasasingam, G., Tompkins, L., & Quik, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00488-2 · Cited by 68 · see citing works

Nicotinic receptors as CNS targets for Parkinson's disease

Quik, M., Bordia, T., & O’Leary, K. T. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.015 · Cited by 116 · see citing works